Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IN-PART is a specialized digital matchmaking platform that facilitates strategic collaborations between academic institutions and industry R&D departments. The company's primary offerings include 'Connect,' a platform for university technology transfer offices to showcase innovations, and 'Discover,' a bespoke scouting service for industry professionals seeking specific research solutions. While serving multiple technology sectors, IN-PART maintains a heavy focus on the life sciences, biotechnology, and healthcare industries. By streamlining the identification of early-stage research and expertise, the platform accelerates the commercialization of academic breakthroughs. In 2022, IN-PART was acquired by Informa Pharma Intelligence, which subsequently became part of Citeline. Today, it serves a global network of hundreds of universities and thousands of R&D-intensive companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IN-PART.